united therapeutics glp-1 receptor agonist Services for Type 2 Diabetes and Obesity Drug Development Biased agonism and polymorphic variation
Description
70 Patients who proactively follow dietary changes may require greater dose reductions of sulphonylureas or insulin to avoid hypoglycaemia
L.LawitzE
Adverse effects Most people are able to tolerate DPP-4 inhibitors fairly well
10.3390/antiox10081257 Antioxidants (Basel) 67 RawlingsA.SharrettA.SchneiderA.CoreshJ.AlbertM.CouperD.et al (2014)
These steps help reduce risks while keeping the good effects of the treatment
